These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 23529761

  • 1. The role of amyloidogenic protein oligomerization in neurodegenerative disease.
    Lotz GP, Legleiter J.
    J Mol Med (Berl); 2013 Jun; 91(6):653-64. PubMed ID: 23529761
    [Abstract] [Full Text] [Related]

  • 2. Functional Reciprocity of Amyloids and Antimicrobial Peptides: Rethinking the Role of Supramolecular Assembly in Host Defense, Immune Activation, and Inflammation.
    Lee EY, Srinivasan Y, de Anda J, Nicastro LK, Tükel Ç, Wong GCL.
    Front Immunol; 2020 Jun; 11():1629. PubMed ID: 32849553
    [Abstract] [Full Text] [Related]

  • 3. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.
    Ilie IM, Caflisch A.
    Chem Rev; 2019 Jun 26; 119(12):6956-6993. PubMed ID: 30973229
    [Abstract] [Full Text] [Related]

  • 4. Autophagy Modulation as a Treatment of Amyloid Diseases.
    Mputhia Z, Hone E, Tripathi T, Sargeant T, Martins R, Bharadwaj P.
    Molecules; 2019 Sep 16; 24(18):. PubMed ID: 31527516
    [Abstract] [Full Text] [Related]

  • 5. Exploring the polymorphism, conformational dynamics and function of amyloidogenic peptides and proteins by temperature and pressure modulation.
    Ostermeier L, de Oliveira GAP, Dzwolak W, Silva JL, Winter R.
    Biophys Chem; 2021 Jan 16; 268():106506. PubMed ID: 33221697
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amyloid Prefibrillar Oligomers: The Surprising Commonalities in Their Structure and Activity.
    Diociaiuti M, Bonanni R, Cariati I, Frank C, D'Arcangelo G.
    Int J Mol Sci; 2021 Jun 16; 22(12):. PubMed ID: 34208561
    [Abstract] [Full Text] [Related]

  • 8. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
    Werner T, Horvath I, Wittung-Stafshede P.
    J Parkinsons Dis; 2020 Jun 16; 10(3):819-830. PubMed ID: 32538869
    [Abstract] [Full Text] [Related]

  • 9. Amyloids: Regulators of Metal Homeostasis in the Synapse.
    Kawahara M, Kato-Negishi M, Tanaka KI.
    Molecules; 2020 Mar 23; 25(6):. PubMed ID: 32210005
    [Abstract] [Full Text] [Related]

  • 10. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
    Glabe CG.
    Neurobiol Aging; 2006 Apr 23; 27(4):570-5. PubMed ID: 16481071
    [Abstract] [Full Text] [Related]

  • 11. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation.
    Bhasne K, Mukhopadhyay S.
    Proteomics; 2018 Nov 23; 18(21-22):e1800059. PubMed ID: 30216674
    [Abstract] [Full Text] [Related]

  • 12. Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.
    Liu T, Bitan G.
    ChemMedChem; 2012 Mar 05; 7(3):359-74. PubMed ID: 22323134
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.
    Kumar S, Thangakani AM, Nagarajan R, Singh SK, Velmurugan D, Gromiha MM.
    Sci Rep; 2016 Feb 29; 6():22258. PubMed ID: 26924748
    [Abstract] [Full Text] [Related]

  • 14. Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates.
    Hashimoto M, Ho G, Takamatsu Y, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Masliah E.
    J Parkinsons Dis; 2018 Feb 29; 8(3):405-408. PubMed ID: 30010144
    [Abstract] [Full Text] [Related]

  • 15. Screening Carbon Nano Materials for Preventing Amyloid Protein Aggregation by Adopting a Facile Method.
    Wilson DL, Carreon A, Chinnam S, Sharifan H, Ahlawat J, Narayan M.
    Cell Biochem Biophys; 2024 Jun 29; 82(2):1389-1395. PubMed ID: 38802601
    [Abstract] [Full Text] [Related]

  • 16. Misfolding of amyloidogenic proteins and their interactions with membranes.
    Relini A, Marano N, Gliozzi A.
    Biomolecules; 2013 Dec 27; 4(1):20-55. PubMed ID: 24970204
    [Abstract] [Full Text] [Related]

  • 17. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM.
    Neuropathol Appl Neurobiol; 2004 Jun 27; 30(3):215-24. PubMed ID: 15175075
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
    Arawaka S, Machiya Y, Kato T.
    Curr Pharm Biotechnol; 2010 Feb 27; 11(2):158-66. PubMed ID: 20170473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.